ResearcherChiba Cancer CenterNo recent work listed
Tadamichi Denda
Matched on ORCID iD 0000-0003-2570-9692; OpenAlex author ID A5053544331. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2011: 2 papers · 2012: 1 paper
Papers 3
- Usefulness of brush cytology combined with pancreatic juice cytology in the diagnosis of pancreatic cancer: significance of pancreatic juice cytology after bru… Last author DOI 10.1097/mpa.0b013e31825d60fc↗
- Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer. Co-author DOI 10.1007/s00280-010-1311-3↗
- Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2010.01.027↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Taketo Yamaguchi · 3 shared papers, 2011–2012 · strength 0.08
- Paper Usefulness of brush cytology combined with pancreatic juice cytology in the diagnosis of pancreatic cancer: significanc… DOI 10.1097/mpa.0b013e31825d60fc↗
- Paper Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer. DOI 10.1007/s00280-010-1311-3↗
- Paper Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. DOI 10.1016/j.ijrobp.2010.01.027↗
- Kentaro Sudo · 3 shared papers, 2011–2012 · strength 0.08
- Paper Usefulness of brush cytology combined with pancreatic juice cytology in the diagnosis of pancreatic cancer: significanc… DOI 10.1097/mpa.0b013e31825d60fc↗
- Paper Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer. DOI 10.1007/s00280-010-1311-3↗
- Paper Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. DOI 10.1016/j.ijrobp.2010.01.027↗
- Osamu Yokosuka · 2 shared papers, 2011 · strength 0.05
- Takashi Uno · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.